Device Trial Radar · NCT07700043
Noise Reduction With Hearing Aids
Last checked: Nov 20, 2026Latest source record: Jul 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Sep 2026
Primary completion
Sep 2029
Study completion Sep 2029
Sponsor
- Lead sponsor
- NYU Langone HealthAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute on Deafness and Other Communication Disorders (NIDCD)
- First posted
- Jul 13, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to use an optimized version of the SEDA algorithm (SEDA-HA) for hearing aids to evaluate the benefit for listeners with varying degrees of hearing loss in realistic environments and evaluate its impact on speech perception and sound quality. The primary objective is to evaluate performance with and without the SEDA-HA algorithm on speech perception and speech reception tasks. The secondary objective is to evaluate performance of and experience with SEDA-HA integrated into a portable hearing aid prototype in the laboratory and in real-world situations outside the laboratory.
Conditions
- Bilateral Sensorineural Hearing Loss
Interventions
Speech Enhancement using Decomposition Approach-Hearing Aid (SEDA-HA) algorithmDevice
All participants will complete the testing using the SEDA-HA algorithm.
Hearing aid (HA) prototype with SEDA-HA algorithmDevice
The study device is a non-invasive, acoustic hearing aid prototype developed by York Sound. Participants ages 18 and older will then take-home the HA prototype to begin the at home protocol for 30 days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of words repeated with SEDATime frame: Day 1 (up to 4 hours)
- Number of words repeated without SEDATime frame: Day 1 (up to 4 hours)
- Number of participants who preferred SEDA-on conditionTime frame: Day 30
Locations
1 site in 1 country. Site status is shown where the registry gives one.
NYU Langone Health
New York, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.